Please use this identifier to cite or link to this item:
http://repositorio.ufla.br/jspui/handle/1/41546| metadata.artigo.dc.title: | Drug repositioning is an alternative for the treatment of coronavirus COVID-19 |
| metadata.artigo.dc.creator: | Serafin, Marissa B. Bottega, Angelita Foletto, Vitória S. Rosa, Taciéli F. da Hörner, Andreas Hörner, Rosmari |
| metadata.artigo.dc.subject: | COVID-19 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |
| metadata.artigo.dc.publisher: | Elsevier |
| metadata.artigo.dc.date.issued: | Jun-2020 |
| metadata.artigo.dc.identifier.citation: | SERAFIN, M. B. et al. Drug repositioning is an alternative for the treatment of coronavirus COVID-19. International Journal of Antimicrobial Agents, [S.l.], v. 55, n. 6, June 2020. |
| metadata.artigo.dc.description.abstract: | Given the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-CoV, with the potential for use in the treatment of COVID-19 disease. |
| metadata.artigo.dc.identifier.uri: | https://www.sciencedirect.com/science/article/pii/S0924857920301266 http://repositorio.ufla.br/jspui/handle/1/41546 |
| metadata.artigo.dc.language: | en_US |
| Appears in Collections: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.